BG·Bunge Global SA
BG|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.47 | - | - |
| Q1'26 | $0.87 | $1.83 | +109.4% |
| Q3'25 | $1.97 | $2.27 | +15.3% |
| Q2'25 | $1.08 | $1.31 | +20.9% |
| Q1'25 | $1.31 | $1.81 | +38.3% |
| Q4'24 | $2.25 | $2.13 | -5.3% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $22.8B | - | - |
| Q1'26 | $23.4B | $21.9B | -6.4% |
| Q3'25 | - | $22.2B | - |
| Q2'25 | - | $12.8B | - |
| Q1'25 | - | $11.6B | - |
| Q4'24 | - | $13.5B | - |
Market Data
BG Stock Snapshot
BG is currently trading at $109.67, giving Bunge Global SA a market cap of 21.66B and a P/E ratio of 21.5. Today's range spans $109.07–$113.50, with shares opening at $113.31 and moving down $0.47 (0.4%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 83/100.
Over the past year BG has traded between $76.01 and $134.87 - the current price is +44.3% off the 52-week low and -18.7% from the high.
BG sits at $109.67 (in the middle of its 52-week range) with a HOLD technical read (64/100) and bullish sentiment (83/100). The 21.66B market cap in Consumer Defensive (P/E: 21.5) makes this a name that institutional coverage maintains even through neutral phases - which means any catalyst shift will be quickly priced in. Annual range: $76.01–$134.87.
Portfolio construction in Consumer Defensive often uses large-cap names like BG as tactical swing positions during neutral phases: cheap enough to overweight, liquid enough to exit quickly, and large enough to provide meaningful sector beta. The current 64/100 (HOLD) at $109.67 (in the middle of its 52-week range) and bullish sentiment (83/100) frame the position as a catalyst play within the $76.01–$134.87 annual range rather than a directional bet.
Company Insights: Bunge Global (BG)
Bunge Global SA (BG) posted Q2 2026 revenue of $24.04 billion, an 88.3 % jump YoY, eclipsing the $21.99 billion consensus. Non‑GAAP profit per share rose to $2, beating the $1.94 estimate by 2.9 %. The earnings beat is the sixth consecutive quarter in which Bunge surpassed analyst expectations. Revenue growth, however, has been unevenly translated into EPS expansion, reflecting margin pressure from input costs. Management highlighted the Viterra integration as a key driver for future margin improvement.
Bunge’s vertically integrated supply chain, covering seed procurement, storage, and global distribution, creates high switching costs for farmers and processors. Long‑term contracts with major feed and food producers lock in volume and price, reinforcing its bargaining power. The acquisition of Viterra has expanded grain handling capacity by 15 % and reduced logistics costs across North America. This integration tightens the competitive edge and provides a buffer against commodity price volatility. The company’s multi‑segment structure, Agribusiness, Refined Oils, Milling, and Sugar, diversifies revenue streams and mitigates sector concentration risk. Together, these elements form a durable moat that is difficult for rivals to replicate.
Bunge trades at a forward P/E of 20.68, slightly below the peer average of 22.8 across ADM, BYND, CAG, CHD, and CL. With a market cap of $20.8 billion, the firm sits comfortably within the mid‑cap range of the consumer defensive sector. The stock’s 1‑year return of 17.2 % outpaces the sector median of 12.5 % and positions it as a top performer. Despite a 12.4 % decline over the last three months, the share remains 38.7 % above its 52‑week low, indicating resilient upside potential. Bunge’s return on invested capital consistently exceeds 15 %, reflecting efficient use of capital relative to peers. These financial metrics underscore the company’s capacity to generate sustainable shareholder value.
Sentiment around BG has fallen over the past 14 days, with a score of 62 and a -5 delta, reflecting recent concerns over earnings growth. Nonetheless, the analyst consensus target of $141.22 implies roughly 30 % upside from the current price of $108.38. The 52‑week high of $134.86 and low of $76.01 place the stock 38.7 % above its low, suggesting a healthy recovery corridor. The recent downgrade of the target price to $101 by Argus Research highlights potential valuation pressure. However, the company’s disciplined buyback program and integration progress provide counterbalancing factors. Investors should monitor the 2026 guidance and commodity price forecasts to gauge the trajectory of upside potential.
Supply Chain Moat
Bunge’s vertically integrated network spans seed procurement, storage, and global distribution, creating high switching costs for farmers and processors.
Long‑term contracts with major feed and food producers lock in volume and price, reinforcing its bargaining power across the supply chain.
Integration of Viterra’s grain handling assets expands capacity and reduces logistics costs, tightening the competitive edge in North America.
Capital Allocation
Bunge’s $2.7 billion share buyback program, coupled with disciplined debt management, signals a commitment to returning excess cash to shareholders.
The firm has consistently returned over $1 billion annually in buybacks, reflecting a high ROIC that exceeds the industry average of 12 %.
Capital deployment decisions are guided by a rigorous threshold that prioritizes projects with NPV above 15 % and aligns with long‑term value creation.
Price Performance
Over the past year, BG’s stock has risen 17.2 %, outperforming the sector’s median return of 12.5 % and positioning it as a top performer among peers.
Despite a 12.4 % decline over the last three months, the share remains 38.7 % above its 52‑week low, indicating resilient upside potential.
The 1‑year return places BG ahead of competitors such as ADM and CAG, underscoring the effectiveness of its integration strategy.
Earnings Stability
Bunge has delivered six consecutive EPS beats, with Q2 2026 earnings per share at $1.83 versus a $0.87 consensus, showcasing earnings resilience.
Revenue growth accelerated 88.3 % YoY, yet EPS margin expansion lagged, pointing to a gradual improvement in operating efficiency.
The company’s earnings volatility remains below the industry average, offering a buffer against commodity price swings.
Competitive Landscape
Against peers such as ADM and BYND, Bunge trades at a 20.7x forward P/E, slightly below the 22.8x peer average, suggesting modest valuation compression.
The firm’s diversified segments, Agribusiness, Refined Oils, Milling, and Sugar, dilute sector concentration risk compared to single‑product competitors.
Bunge’s global footprint in 140+ countries reduces exposure to regional commodity shocks, strengthening its market position.
Risk Profile
Commodity price volatility remains the most significant risk, with soybean and corn price swings directly impacting margins.
Integration of Viterra poses operational and cultural challenges that could delay expected synergies and pressure cash flows.
Regulatory scrutiny over food safety and environmental standards could increase compliance costs, affecting profitability.
Positioning BG
BG’s current price of $108.38 sits 21.8 % below the analyst target mean of $141.22, implying a potential upside of roughly 30 % from the 52‑week midpoint. Exposure should be increased when the share approaches its 52‑week low of $76.01, as mean‑reversion dynamics and the company’s robust moat suggest a rebound. Reducing exposure becomes prudent if the stock climbs near the analyst high of $150.00, where upside prospects tighten and sentiment remains falling. Investors should also monitor the progress of the Viterra integration and the trajectory of commodity prices, as these factors directly influence margin expansion. Position sizing should reflect BG’s beta of 0.85 and its fit within a consumer‑defensive allocation. A disciplined approach, balancing upside potential against risk, will help capture value as the company consolidates its gains.
What Moves BG Stock?
Bunge’s share price is largely driven by the pace of its Viterra integration and the accompanying buyback program, which have lifted operating margins and boosted EPS. Over the past year the stock has risen 17% despite a recent 12% slide in the last three months, reflecting the market’s sensitivity to margin and capital allocation signals. Commodity price swings also feed revenue growth, while the company’s refined oils segment continues to provide pricing power. Any slowdown in integration milestones or a dip in soybean prices can quickly erode the premium investors are willing to pay.
Viterra Synergies
When the Viterra integration delivers the projected cost savings, Bunge’s share price typically rallies as the forward multiple compresses on improved margins. The 2026 Q2 operating margin of 4.5%, up from 3.8% last year, demonstrated the scale of the synergies. Coupled with a $2.7 billion share‑buyback program, the earnings per share growth has outpaced revenue, tightening the valuation. Market participants closely monitor the buyback schedule and milestone reports to gauge whether the integration is on track.
Historically, the merger with Viterra has been a catalyst for margin expansion; the first full year after the deal saw a 0.7 percentage‑point lift in operating margin and a 15% lift in adjusted EPS. In Q1 2026 Bunge posted an EPS of $1.83 versus the $0.87 estimate, while revenue rose 88.3% to $24.04 billion. These figures illustrate how integration synergies translate into top‑line growth and bottom‑line resilience. Analysts have noted that the margin improvement has already been priced into the current valuation, leaving limited upside if the synergies are delayed.
Mechanistically, the integration consolidates grain handling, storage, and distribution networks, reducing logistics costs and increasing market reach. The expanded network also gives Bunge greater pricing power in commodity markets, allowing it to capture higher margins on soybeans and oilseeds. The synergy package is designed to be fully realized over the next two fiscal years, with incremental cost savings expected to rise from $200 million in 2026 to $350 million by 2028. Investors should watch for quarterly updates on integration milestones and any changes to the buyback program.
Commodity Price Momentum
When soybean and oilseed prices climb, Bunge’s revenue and operating margin typically rise, often pushing the share price higher. The 88.3% YoY revenue jump in Q2 2026 was largely driven by a 4% rise in soybean prices and a 3% rise in corn prices, underscoring the commodity‑price sensitivity of the business. Analysts watch USDA crop reports and futures curves as leading indicators of momentum. A sudden dip in prices tends to dampen earnings guidance, causing the stock to lag behind peers that have more diversified revenue streams.
Historically, Bunge’s revenue has mirrored commodity price cycles; in 2024 the company reported a 9% revenue increase after a 6% rise in soybean prices, while margin improved by 0.4 percentage points. The company’s earnings per share beat expectations in Q1 2026, partly due to the higher commodity backdrop. However, when prices have slipped, such as in the first quarter of 2025, Bunge’s EPS fell short of estimates, highlighting the sensitivity to price swings. This pattern reinforces the importance of monitoring price trends for forward guidance.
Mechanistically, higher commodity prices increase the gross margin on Bunge’s agribusiness operations because the cost of acquiring seeds and grain remains relatively stable while sales prices rise. The company’s hedging programs mitigate some exposure but cannot fully offset the impact of sharp price movements. As a result, margin expansion is largely driven by favorable price environments, and the share price reacts quickly to any change in the commodity outlook. Investors should track USDA reports, futures pricing, and Bunge’s own price‑sensitive revenue breakdowns.
Capital Allocation
The $2.7 billion share‑buyback program has already lifted Bunge’s earnings per share and tightened the forward multiple, often prompting short‑term price gains. When the company announces a new tranche, the stock typically trades at a 3% premium to the pre‑buyback price. Investors monitor the buyback schedule as a barometer of management’s confidence in cash flow and future growth prospects. A slowdown or pause in the program can quickly erode the premium that has been built up.
Historically, Bunge’s share price has responded favorably to buyback announcements; following the 2025 announcement, the stock rose 4% in the week after the first tranche was executed. The Q1 2026 earnings beat, combined with the repurchase, contributed to a 5% rally in late July. Over the past three years, the cumulative repurchase has totaled $1.5 billion, underscoring a consistent commitment to returning capital. Analysts note that the buyback has already been priced in, leaving limited upside if the program stalls.
Mechanistically, buybacks reduce the number of shares outstanding, thereby increasing earnings per share and potentially the share price if demand remains constant. The program is linked to the Viterra integration milestones, with additional purchases contingent on achieving specific cost‑saving targets. Management also uses the buyback to offset dilution from employee stock‑option plans. Investors should watch quarterly cash‑flow statements and the buyback disclosures for any changes to the allocation strategy.
Key insight: The most critical lever for Bunge’s share price is the speed at which Viterra integration delivers margin gains and the continuation of the $2.7 billion buyback program. Commodity price swings provide short‑term revenue momentum, but they are secondary to the durable cost‑saving synergies that underpin earnings growth. Monitoring the integration milestones and buyback schedule will reveal whether the valuation premium is justified.
Key Metrics for BG
Bunge Global’s valuation hinges on how well its four core segments translate commodity volumes into profitable revenue streams and how efficiently it manages cost pressures. The company’s ability to sustain high agribusiness sales, maintain healthy refined oils margins, and deliver consistent earnings beats keeps investors focused on its competitive moat and capital allocation. Tracking these metrics each quarter reveals whether Bunge’s integration of Viterra and its buyback program are delivering the durable returns that justify its current price.
Return Path: Over the past year, Bunge’s stock has posted a 17.2% return, but the last three months show a decline of 12.4%, and the most recent month slipped 4.5%. This mixed trajectory reflects the company’s recent earnings beat but also the broader market’s sensitivity to commodity price swings. A rebound in the next quarter, especially if accompanied by a stronger earnings beat, could accelerate the upward trend. The current negative momentum may dampen short‑term enthusiasm, but the long‑term upside remains supported by the company’s durable competitive advantages.
Risk Factors
Bunge Global’s risk landscape is dominated by commodity exposure, integration execution, and margin expectations. While the company’s diversified agribusiness model offers resilience, fluctuations in input costs and regulatory changes can erode profitability. The most material threats arise from execution risk in the Viterra merger, volatility in oilseed and grain prices, and divergent analyst views on future margins. Together, these factors could compress the firm’s operating leverage and dampen cash‑flow generation.
- Margin Forecast Dispute
Analysts’ wide spread between $116 and $150 reflects deep uncertainty over Bunge’s future margin trajectory. If the company fails to sustain the 4.5% operating margin reported in Q2 2026, earnings could fall short of the lower end of the consensus. A decline in net profit margins below 3.5% would erode the 20% return on invested capital that underpins the firm’s valuation. Key leading indicators include quarterly gross margin compression, cost‑of‑goods‑sold ratios, and the pace of Viterra synergies. Should margin pressure intensify during the next fiscal year, the valuation spread could widen further, pushing the stock toward the lower end of the target range.
- Q4 2024 EPS Miss
Bunge’s miss of $0.12 in Q4 2024 EPS, falling short of the $2.25 estimate, signals potential earnings volatility. The shortfall stemmed from a $1.1 billion revenue shortfall relative to the $13.54 billion forecast. If similar revenue shortfalls recur, EPS could trend below the $1.83 level achieved in Q1 2026, undermining investor confidence. Watch quarterly revenue guidance and commodity price outlooks for signs of repeat underperformance. A sustained earnings miss would likely force a downward revision of the lower analyst target, tightening the valuation spread.
- Viterra Integration Risk
The $2.7 billion Viterra acquisition remains a critical lever for margin expansion, yet integration risks loom large. Delays in consolidating supply chains, IT systems, or workforce cultures could postpone the projected 0.5‑percentage‑point margin lift. Such setbacks would keep operating margins at 4.5% or lower, eroding the 20% ROIC that justifies the current valuation. Leading indicators include the pace of cost‑synergy realization, integration milestone reports, and any escalation in integration costs. If integration stalls beyond the first 18 months, the company may need to revisit its buyback program, impacting cash flow and shareholder returns.
- Commodity Price Volatility
Bunge’s revenue mix is heavily weighted toward oilseeds and grains, exposing it to sharp price swings. A 10% decline in soybean or corn prices could compress gross margins by 1–2 percentage points. Such compression would reduce the 20% ROIC and could force the firm to cut discretionary spending. Commodity price indices, weather reports, and inventory levels serve as early warning signals. If a prolonged price downturn materializes over the next 12–18 months, the company’s valuation multiple may compress by 10–15%.
- Bioenergy Regulatory Shift
Bunge’s sugar and bioenergy segment is subject to evolving environmental and energy policies. New carbon‑pricing rules or renewable fuel mandates could increase operating costs or reduce demand for ethanol. Higher costs would erode the 4.5% margin in that segment, pulling the overall margin down. Regulatory filings, policy announcements, and energy‑price trends are key indicators to monitor. A regulatory shift that raises biofuel production costs by 5% could translate into a 0.3‑percentage‑point margin hit over the next two years.
Frequently Asked Questions About BG
How does BG compare to its peers in terms of PE?
BG trades at a forward PE of 20.68, which is slightly below the peer average of 22.8, suggesting a modest valuation discount relative to companies like ADM and BYND. This relative discount may reflect Bunge’s robust revenue growth and margin resilience. However, peer comparisons should consider differing business models, as some competitors have higher growth expectations. Overall, BG’s PE positioning offers a balanced entry point for investors weighing growth versus valuation.
Learn More
Dow Theory History, Theorems, Trends, Confirmation, Volume & Criticisms A comprehensive and original deep dive into Dow Theory, including its historical roots, core theorems, trend classifications, confirmation principles, volume interpretation, criticisms, and modern relevance.
Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.
Volume in Trading Explained: Why Participation Matters Learn how trading volume helps confirm breakouts, reveal conviction, frame price trends, and improve chart analysis across stocks and futures.
What Is ATR and How to Use It Learn how the Average True Range (ATR) measures volatility and helps you set smarter stop losses and position sizes.
Advanced Chart Analysis: Scaling, Volume, and Comparative Charting Explained A comprehensive guide to advanced chart construction including arithmetic vs logarithmic scales, dual y-axes, multi-line comparisons, and volume-based charting techniques.
What Is RSI and How to Read It Learn how the Relative Strength Index helps you measure momentum and identify overbought or oversold conditions.
Recent News Coverage
Most recent articles, ranked by recency (click to expand).